Dronabinol is a safe long-term treatment option for neuropathic pain patients
European Neurology Oct 31, 2017
Schimrigk S, et al. - Researchers carried out a clinical trial to show efficacy and long-term safety of dronabinol in the treatment of patients with multiple sclerosis (MS) and central neuropathic pain (CNP). In this study, dronabinol was found to be a safe long-term treatment option.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
